| CDTX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CDTX market cap history going back to 4/15/2015:
Also see: CDTX Shares Outstanding History and CDTX YTD Return |
CDTX Market Cap History — Cidara Therapeutics Capitalization Over Time
As of 11/3/2025 Cidara Therapeutics has a market cap of 3.23 billion. Investors often follow the CDTX market cap history to compare the size of the company over time.
This page shows CDTX market capitalization trends over time, with 45 market cap datapoints presented, dating back to 4/15/2015.
| CDTX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDTX Historical Market Cap: +29.94% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CDTX Stock Price Chart |
| About Cidara Therapeutics Inc |
| Cidara Therapeutics, Inc. is a biotechnology company. Co. is developing targeted immunotherapies designed for patients facing serious diseases. Co.'s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. Co. is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as advancing other pipeline assets. CBO421 is a development candidate targeting CD73 for the treatment of solid tumors. We show 45 historical shares outstanding datapoints in our CDTX shares outstanding history coverage, used to compute CDTX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CDTX market cap history over the course of time is important for investors interested in comparing CDTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CDTX versus a peer is one thing; comparing CDTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CDTX can fluctuate over the course of history. With this page we aim to empower investors researching CDTX by allowing them to research the CDTX market cap history. |
| CDTX Current Stock Quote |
Quotes delayed 20 minutes  Free CDTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| CDTX Share Performance |
| Market Cap Peers |
| Cidara Therapeutics (CDTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CDXC Market Cap History CELC Market Cap History CELG Market Cap History CELL Market Cap History CELU Market Cap History CELZ Market Cap History CEMI Market Cap History CERC Market Cap History CERE Market Cap History CERS Market Cap History More Healthcare companies » |
CDTX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
